| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | FAB5519A | |||
| Carrier Free | MAB5519-SP | |||
| Carrier Free | FAB5519V-100UG | |||
| Carrier Free | FAB5519U-100UG | |||
| Carrier Free | FAB5519T-100UG | |||
| Carrier Free | FAB5519S-100UG | |||
| Carrier Free | FAB5519R-100UG | |||
| Carrier Free | FAB5519N-100UG | |||
| Carrier Free | FAB5519G-100UG | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Carrier Free | MAB2350-SP | |||
| Carrier Free | FAB2350V-100UG | |||
| Carrier Free | FAB2350U-100UG | |||
| Carrier Free | FAB2350T-100UG | |||
| Carrier Free | FAB2350S-100UG | |||
| Carrier Free | FAB2350R-100UG | |||
| Carrier Free | FAB2350N-100UG | |||
| Carrier Free | FAB2350G-100UG | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-11970-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-11982-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-11981-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP3-11983-0.025mg | |||
| Formulation | Catalog # | Availability | Price | |
|---|---|---|---|---|
| Azide and BSA Free | NBP2-12137-0.025mg | |||
![Western Blot: CCRL2/CRAM-A/B Antibody (BZ5B8) - Chimeric [NBP3-11970] - Mouse thymus (A) and mouse brain (B) tissue lysates (35ug protein in RIPA buffer) were resolved on a SDS PAGE gel and blots were probed with the chimeric rabbit version of CCRL2 (NBP3-11970) at 0.5 ug/ml, before detection using an anti-rabbit secondary antibody. A primary incubation of 1h was used and protein was detected by chemiluminescence.](http://images.novusbio.com/fullsize/CCRL2-CRAM-A-B-Antibody-BZ5B8-Chimeric-Western-Blot-NBP3-11970-img0001.jpg "Western Blot: CCRL2/CRAM-A/B Antibody (BZ5B8) - Chimeric [NBP3-11970] - Mouse thymus (A) and mouse brain (B) tissue lysates (35ug protein in RIPA buffer) were resolved on a SDS PAGE gel and blots were probed with the chimeric rabbit version of CCRL2 (NBP3-11970) at 0.5 ug/ml, before detection using an anti-rabbit secondary antibody. A primary incubation of 1h was used and protein was detected by chemiluminescence.")
![Immunocytochemistry/Immunofluorescence: CCRL2/CRAM-A/B Antibody (BZ5B8) - Chimeric [NBP3-11970] - Immunofluorescence analysis of paraformaldehyde fixed RAW264.7 cells on Shi-fix(TM) coverslips stained with the chimeric rabbit IgG version of BZ5B8 (NBP3-11970) at 10 ug/ml for 1h followed by Alexa Fluor(R) 488 secondary antibody (2 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-11970, DAPI, merged channels and an isotype control. The isotype control was an unknown specificity antibody followed by staining with Alexa Fluor(R) 488 secondary antibody.](http://images.novusbio.com/fullsize/CCRL2-CRAM-A-B-Antibody-BZ5B8-Chimeric-Immunocytochemistry-Immunofluorescence-NBP3-11970-img0002.jpg)
![Immunocytochemistry/Immunofluorescence: CCRL2/CRAM-A/B Antibody (BZ2E3) - Chimeric [NBP3-11982] - Immunofluorescence analysis of paraformaldehyde fixed RAW264.7 cells on Shi-fix(TM) coverslips stained with the chimeric rabbit IgG version of BZ2E3 (NBP3-11982) at 10 ug/ml for 1h followed by Alexa Fluor(R) 488 secondary antibody (2 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-11982, DAPI, merged channels and an isotype control. The isotype control was an unknown specificity antibody followed by staining with Alexa Fluor(R) 488 secondary antibody.](http://images.novusbio.com/fullsize/CCRL2-CRAM-A-B-Antibody-BZ2E3-Chimeric-Immunocytochemistry-Immunofluorescence-NBP3-11982-img0001.jpg "Immunocytochemistry/Immunofluorescence: CCRL2/CRAM-A/B Antibody (BZ2E3) - Chimeric [NBP3-11982] - Immunofluorescence analysis of paraformaldehyde fixed RAW264.7 cells on Shi-fix(TM) coverslips stained with the chimeric rabbit IgG version of BZ2E3 (NBP3-11982) at 10 ug/ml for 1h followed by Alexa Fluor(R) 488 secondary antibody (2 ug/ml), showing membrane staining. The nuclear stain is DAPI (blue). Panels show from left-right, top-bottom NBP3-11982, DAPI, merged channels and an isotype control. The isotype control was an unknown specificity antibody followed by staining with Alexa Fluor(R) 488 secondary antibody.")
![Immunohistochemistry-Paraffin: CCRL2/CRAM-A/B Antibody [NLS1093] - Human spleen tissue after heat-induced antigen retrieval.](http://images.novusbio.com/fullsize/CCRL2-CRAM-A-B-Antibody-Immunohistochemistry-Paraffin-NLS1093-img0007.jpg "Immunohistochemistry-Paraffin: CCRL2/CRAM-A/B Antibody [NLS1093] - Human spleen tissue after heat-induced antigen retrieval.")
![Immunohistochemistry-Paraffin: CCRL2/CRAM-A/B Antibody [NLS1093] - Analysis of anti-CCRL2 antibody with human lymph node, Hodgkins lymphoma.](http://images.novusbio.com/fullsize/CCRL2-CRAM-A-B-Antibody-Immunohistochemistry-Paraffin-NLS1093-img0005.jpg)
![Immunohistochemistry-Paraffin: CCRL2/CRAM-A/B Antibody [NLS1093] - Human Ovary, Carcinoma tissue after heat-induced antigen retrieval.](http://images.novusbio.com/fullsize/CCRL2-CRAM-A-B-Antibody-Immunohistochemistry-NLS1093-img0006.jpg)
![Immunohistochemistry-Paraffin: CCRL2/CRAM-A/B Antibody [NBP1-85588] - Staining of human spleen shows moderate cytoplasmic positivity in cells in red pulp and cells in white pulp.](http://images.novusbio.com/fullsize/CCRL2-CRAM-A-B-Antibody-Immunohistochemistry-Paraffin-NBP1-85588-img0005.jpg "Immunohistochemistry-Paraffin: CCRL2/CRAM-A/B Antibody [NBP1-85588] - Staining of human spleen shows moderate cytoplasmic positivity in cells in red pulp and cells in white pulp.")
![Western Blot: CCRL2 Antibody [NBP1-85588] - Analysis in human cell line HEL.](http://images.novusbio.com/fullsize/antibody/nbp1-85588_rabbit-polyclonal-ccrl2-cram-a-b-antibody-western-blot-4102023101629..jpg)
![Western Blot: CCRL2/CRAM-A/B Antibody [NBP2-15769] - Whole cell extract (30 ug) was separated by 10% SDS-PAGE, and the membrane was blotted with CCRL2 antibody [N1], N-term diluted at 1:500.](http://images.novusbio.com/fullsize/CCRL2-CRAM-A-B-Antibody-Western-Blot-NBP2-15769-img0003.jpg "Western Blot: CCRL2/CRAM-A/B Antibody [NBP2-15769] - Whole cell extract (30 ug) was separated by 10% SDS-PAGE, and the membrane was blotted with CCRL2 antibody [N1], N-term diluted at 1:500.")
![Western Blot: CCRL2/CRAM-A/B Antibody [NBP2-15769] - Sample (30 ug of whole cell lysate) A: NIH-3T3 10% SDS PAGE gel, diluted at 1:1000.](http://images.novusbio.com/fullsize/CCRL2-CRAM-A-B-Antibody-Western-Blot-NBP2-15769-img0002.jpg)
![Immunohistochemistry-Paraffin: CCRL2/CRAM-A/B Antibody (MM0158-5A15) [NBP2-12137] - 10% Buffer formalin fixed and parffine embedded human placetal tissue section (4um) is subjected IHC staining using NBP2-12137. Tissue section was pretreated in citric buffer (pH 6.0) with microwave for antige retrieval before IHC is applied.](http://images.novusbio.com/fullsize/CCRL2-CRAM-A-B-Antibody-MM0158-5A15-Immunohistochemistry-Paraffin-NBP2-12137-img0001.jpg "Immunohistochemistry-Paraffin: CCRL2/CRAM-A/B Antibody (MM0158-5A15) [NBP2-12137] - 10% Buffer formalin fixed and parffine embedded human placetal tissue section (4um) is subjected IHC staining using NBP2-12137. Tissue section was pretreated in citric buffer (pH 6.0) with microwave for antige retrieval before IHC is applied.")
![Western Blot: CCRL2 Overexpression Lysate (Adult Normal) [NBP2-09525] Left-Empty vector transfected control cell lysate (HEK293 cell lysate); Right -Over-expression Lysate for CCRL2.](http://images.novusbio.com/fullsize/CCRL2-Overexpression-Lysate-Adult-Normal-Western-Blot-NBP2-09525-img0001.jpg "Western Blot: CCRL2 Overexpression Lysate (Adult Normal) [NBP2-09525] Left-Empty vector transfected control cell lysate (HEK293 cell lysate); Right -Over-expression Lysate for CCRL2.")